IF: 1.578
Cite Score:
1.45
THOMSON REUTERS - SCOPUS

Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

AUTHORS

Seyed Moayed Alavian 1 , * , Masoud Ahmadzad Asl 2 , maryam keshvari 3 , Bita Behnava 4 , bashir hajibeigi 5

1 Department of Gastroenterology, Baqiyatallah University of Medical Sciences , Dean of Tehran Hepatitis Center, Tehran, Tehran, IR.Iran

2 Methodology and Statistics Consultant, Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran

3 Infectious Specialist, Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran

4 Infectious Specialist, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran

5 Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran

How to Cite: Alavian S M, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran, Hepat Mon. 2006 ; 6(1):e92946.

ARTICLE INFORMATION

Hepatitis Monthly: 6 (1); e92946
Published Online: March 31, 2006
Article Type: Research Article
Received: May 05, 2019
Accepted: March 31, 2006

Crossmark

CHEKING

READ FULL TEXT
Abstract

Keywords

Chronic Hepatitis C Interferon α Ribavirin Iran Treatment Adverse Drug Effects

© 2006, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    The references are available in the PDF file.

  • COMMENTS

    LEAVE A COMMENT HERE: